ACRV
Acrivon Therapeutics, Inc. Common Stock
NASDAQ: ACRV · HEALTHCARE · BIOTECHNOLOGY
$1.81
-4.74% today
Updated 2026-04-29
Market cap
$70.13M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.02
Dividend yield
—
52W range
$1 – $4
Volume
0.9M
Acrivon Therapeutics, Inc. Common Stock (ACRV) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-2.80M | $-13.98M | $-30.12M | $-42.64M | $-65.67M | $-63.66M |
| Capital expenditures | $15000.00 | $238000.00 | $2.17M | $1.29M | $2.77M | $1.67M |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | $3000.00 | $497000.00 | $2.19M | $11.62M | $14.29M | $14.72M |
| Free cash flow | $-2.82M | $-14.22M | $-32.28M | $-43.93M | $-68.44M | $-65.33M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | $-70.08M | — | — | — |